A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway.

Xuejie GaoBo LiAnqi YeHoucai WangYongsheng XieDandan YuZhijian XuBingqing ShiHui ZhangQilin FengKe HuYong ZhangCheng HuangGuang YangJumei ShiWeiliang Zhu

Published in: Cancer cell international (2021)

The findings of this study indicate that DCZ0805 can serve as a novel therapeutic agent for the treatment of MM.

Keyphrases

signaling pathway
lps induced
multiple myeloma
newly diagnosed
anti inflammatory
smoking cessation